Published in Infect Immun on March 01, 1982
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Genetic analysis of phase change in Bordetella pertussis. Infect Immun (1984) 5.03
Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94
Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis. J Bacteriol (1988) 3.88
Reversible expression of flagella in Campylobacter jejuni. Infect Immun (1985) 2.92
Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect Immun (1989) 2.40
Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun (1984) 2.30
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol (2001) 2.02
Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis. J Bacteriol (1983) 1.65
Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol (1990) 1.48
A vir-repressed gene of Bordetella pertussis is required for virulence. Infect Immun (1992) 1.47
Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36
Evidence that modulation requires sequences downstream of the promoters of two vir-repressed genes of Bordetella pertussis. J Bacteriol (1990) 1.35
Influence of potential virulence determinants on Bordetella bronchiseptica-induced ciliostasis. Infect Immun (1985) 1.31
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
Vag8, a Bordetella pertussis bvg-regulated protein. Infect Immun (1998) 1.06
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Antibiotic resistance of degraded strains of Bordetella pertussis. Antimicrob Agents Chemother (1984) 0.96
Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion. Infect Immun (1996) 0.96
Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95
Isolation and characterization of Bordetella avium phase variants. Infect Immun (1991) 0.90
Mutations in the S1 subunit of pertussis toxin that affect secretion. Infect Immun (2000) 0.89
Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV. Infect Immun (1984) 0.87
Cloning and characterization of btr, a Bordetella pertussis gene encoding an FNR-like transcriptional regulator. J Bacteriol (1993) 0.85
Spontaneous phase variation in Bordetella pertussis is a multistep non-random process. EMBO J (1984) 0.82
Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability. J Clin Microbiol (1988) 0.81
Variation in hemolytic activity of Brachyspira hyodysenteriae strains from pigs. Vet Res (2016) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry (1978) 9.04
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci. Infect Immun (1978) 8.19
Serological study of Bordetella pertussis and related species. J Bacteriol (1957) 4.96
Antigenic modulation of Bordetella pertussis. J Hyg (Lond) (1960) 4.61
Preservation of living cells by freeze-drying. Ann N Y Acad Sci (1960) 3.88
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
The growth of Bordetella pertussis: a review. J Gen Microbiol (1957) 2.03
Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo. J Gen Microbiol (1977) 1.85
Studies on Haemophilus pertussis. I. Antigen structure of H. pertussis and its phases. Kitasato Arch Exp Med (1953) 1.68
Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis. Infect Immun (1979) 1.65
Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. J Med Microbiol (1976) 1.57
Crystallization of pertussigen from Bordetella pertussis. Infect Immun (1981) 1.45
Studies on Haemophilis pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch Exp Med (1954) 1.30
Role of the genetics and physiology of Bordetella pertussis in the production of vaccine and the study of host-parasite relationships in pertussis. Adv Appl Microbiol (1976) 1.29
Cell-envelope proteins of Bordetella pertussis. J Med Microbiol (1975) 1.27
Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1979) 1.11
Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis. J Med Microbiol (1968) 1.10
Antigenic structure and phase variation in Bordetella pertussis. Jpn J Microbiol (1969) 1.07
The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis. J Hyg (Lond) (1976) 1.06
Radiolabelling of Bordetella pertussis envelope proteins by the 125 I-lactoperoxidase method. Microbios (1976) 0.89
Areexamination of phase IV Bordetella pertussis. Can J Microbiol (1972) 0.88
Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen. Infect Immun (1971) 0.87
A simple applicator for use in bacteriocin typing. Med Lab Technol (1975) 0.85
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol (1994) 4.13
Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun (1989) 3.27
Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun (1984) 2.30
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect Immun (1982) 1.96
Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85
Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun (1989) 1.78
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol (1993) 1.39
Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36
Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations. Infect Immun (1982) 1.18
Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14
Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J Biol Chem (1988) 1.10
Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun (1992) 1.05
The structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica. Eur J Biochem (2000) 1.02
Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95
Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95
Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology (1997) 0.92
Lectinlike properties of pertussis toxin. Infect Immun (1989) 0.90
Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis. J Clin Microbiol (1995) 0.88
Temperature-sensitive mutants in rfaI and rfaJ, genes for galactosyltransferase I and glucosyltransferase II, for synthesis of lipopolysaccharide in Salmonella typhimurium. Can J Microbiol (1985) 0.88
Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV. Infect Immun (1984) 0.87
Effect of proteolytic enzymes, storage and reduction on the structure and biological activity of pertussigen, a toxin from Bordetella pertussis. Dev Biol Stand (1985) 0.86
Phorbol myristate acetate inhibits HeLa 229 invasion by Bordetella pertussis and other invasive bacterial pathogens. Infect Immun (1990) 0.86
Analysis of Mycobacterium avium complex isolates from blood samples of AIDS patients by pulsed-field gel electrophoresis. J Clin Microbiol (2003) 0.84
Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis. Clin Diagn Lab Immunol (2004) 0.81
An improved immunofluorescent reagent for rapid, direct detection of Bordetella pertussis. Can J Infect Dis (1995) 0.75